Topoisomerase IIa expression in laryngeal and oral carcinomas: is it a reliable prognostic molecular marker?
Dept of Immunohistochemistry & Molecular Biology, 401 General Army Hospital, Athens, Greece.
Evangelos
E
Tsiambas
Panagiotis P
PP
Fotiades
Ioannis
I
Kastanioudakis
Vasileios
V
Ragos
D014408:Biomarkers, Tumor / Q000235:genetics*; D002277:Carcinoma / Q000235:genetics*; D002453:Cell Cycle / Q000235:genetics; D004250:DNA Topoisomerases, Type II / Q000235:genetics*; D006801:Humans; D019394:Ki-67 Antigen / Q000235:genetics; D007822:Laryngeal Neoplasms / Q000235:genetics*; D009062:Mouth Neoplasms / Q000235:genetics*
D014408:Biomarkers, Tumor; D019394:Ki-67 Antigen; D004250:DNA Topoisomerases, Type II